Angina in fabry disease reflects coronary small vessel disease

Cristina Chimenti1, Emanuela Morgante, Gaetano Tanzilli

  • 1Heart and Great Vessels Attilio Reale Department, La Sapienza University, Rome, Italy.

Insights

Chest pain in Fabry disease (FD) is linked to impaired coronary blood flow and narrowed small arteries. This small vessel disease may cause symptoms and worsen heart function over time.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Chest pain is a common symptom in Fabry disease (FD), but its underlying causes and clinical significance remain poorly understood.
  • Investigating the mechanisms of chest pain in FD is crucial for understanding disease progression and patient outcomes.

Purpose of the Study:

  • To elucidate the mechanisms behind chest pain in patients with Fabry disease.
  • To evaluate coronary blood flow, myocardial perfusion, and intramural coronary artery pathology in FD patients experiencing angina.

Main Methods:

  • Coronary angiography, endomyocardial biopsy, and cardiac imaging (SPECT) were performed on 13 FD patients with angina.
  • Histomorphometric analysis assessed intramural artery lumen narrowing (E/L ratio) and fibrosis.
  • Comparison was made with FD patients without angina and mitral stenosis controls.

Main Results:

  • All FD patients with angina showed evidence of myocardial ischemia and perfusion defects on SPECT.
  • Coronary angiography revealed normal epicardial arteries but slow coronary flow in all patients.
  • Histology demonstrated significant narrowing of intramural arteries due to smooth muscle/endothelial cell hypertrophy and fibrosis, associated with glycosphingolipid accumulation.

Conclusions:

  • Patients with Fabry disease and angina exhibit perfusion defects, slow coronary flow, and narrowed intramural arteries.
  • Small vessel disease is implicated as a contributor to symptomatic limitations and progressive myocardial dysfunction in FD.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
369
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
428
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
686
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K